DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2007/0077616 A1 KEASLING Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) Patent Application Publication (10) Pub. No.: US 2007/0077616 A1 KEASLING Et Al US 20070077616A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2007/0077616 A1 KEASLING et al. (43) Pub. Date: Apr. 5, 2007 (54) BIOSYNTHESIS OF ISOPENTENYL Publication Classification PYROPHOSPHATE (51) Int. Cl. CI2P 33/00 (2006.01) (76) Inventors: Jay KEASLING, Berkeley, CA (US); CI2P 17/00 (2006.01) Vincent Martin, Montreal (CA); CI2P 9/00 (2006.01) Douglas Pitera, Oakland, CA (US); CI2P 7/04 (2006.01) Seon-Won Kim, Jeongdon-myeon CI2P 5/00 (2006.01) (KR); Sydnor T. Withers III, CI2P 5/02 (2006.01) Richmond, CA (US); Yasuo Yoshikuni, CI2N 9/10 (2006.01) Berkeley, CA (US); Jack Newman, San CI2N I/2 (2006.01) Francisco, CA (US); Artem C7H 2L/04 (2006.01) Valentinovich Khlebnikov, Mountain CI2N 15/74 (2006.01) View, CA (US) (52) U.S. Cl. ............................ 435/52; 435/117; 435/131; 435/157; 435/166; 435/167; 435/252.3; 435/193; 435/471; Correspondence Address: 536/23.2; 435/252.33 BOZICEVIC, FIELD & FRANCIS LLP 1900 UNIVERSITY AVENUE (57) ABSTRACT SUTE 200 EAST PALO ALTO, CA 94.303 (US) Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid (21) Appl. No.: 11/610,686 sequences, each coding for a different enzyme in the meva lonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microor (22) Filed: Dec. 14, 2006 ganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary Related U.S. Application Data for converting the intermediate into isopentenyl pyrophos phate. The invention also provides nucleic acid sequences, (62) Division of application No. 10/006,909, filed on Dec. enzymes, expression vectors, and transformed host cells for 6, 2001, now Pat. No. 7,172,886. carrying out the methods. Patent Application Publication Apr. 5, 2007 Sheet 1 of 5 US 2007/007761.6 A1 MEVALONATE PATHWAY AND PREFERRED ENZYMES AND SEQUENCES FOR PRODUCING ISOPENTENYL PYROPHOSPHATE STEP PREFERRED PREFERRED ENZYME SEQUENCE O O 2- -- ?' - Acetyl-CoA Acetyl-CoA Acetoacetyl-CoA thiolase SEQ ID NO 1 //C O . Acetoacetyl-CoA HMG-CoA synthase SEQ ID NO2 C O HC JXOl -CoA HMG-CoA Truncated HMG-CoA reductase SEQID NO 3 O HC OH Mevalonate FIG 1A Patent Application Publication Apr. 5, 2007 Sheet 2 of 5 US 2007/007761.6 A1 MEVALONATE PATHWAY AND PREFERRED ENZYMES AND SEQUENCES FOR PRODUCING ISOPENTENYL PYROPHOSPHATE (CONTINUED) STEP PREFERRED PREFERRED ENZYME SEQUENCE O - O OH Mewalionate Mevalonate kinase SEQ ID NO 4 O SpH JXC CH HO e--- O Mevalonate 5-phosphate Phosphomevalonate kinase SEQ ID NO 5 O Sso OH OH HO e---- C| O| Mevalonate 5-pyrophosphate Mevalonate pyrophosphate decarboxylase SEQID NO 6 C H ----- O O Isopentenyl pyrophosphate FIG 1B Patent Application Publication Apr. 5, 2007 Sheet 3 of 5 US 2007/007761.6 A1 12 ETE.coli DH.10B pBBRIMCS-3, E. E.coli DPDXR1 pBBRMBI-2, |||||||||||||||||||||||||||||||||||||||||| E H O mM nM 10 mM. 20 nM 60 |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||nM Mew Mew Mew Mew Mew FIG. 2 pAC -LYC only pBADMEVT, pBBRMBI-2, p.AC LYC FIG. 3 Patent Application Publication Apr. 5, 2007 Sheet 4 of 5 US 2007/007761.6 A1 2. 5 2 5 0. 5 O pTRCADS only pBBRMBI-2 & pTRCADS FIG. 4 Patent Application Publication Apr. 5, 2007 Sheet 5 of 5 US 2007/007761.6 A1 8000 7000 5 O 5 20 25 Retention Time (min) FIG. 5 250000 200000 SOCOC Casbene (Ricinus communis L.) retention time at 16.60 0000 5000 mtz F.G. 6 US 2007/007761.6 A1 Apr. 5, 2007 BIOSYNTHESIS OF SOPENTENYL increase isopentenyl pyrophosphate production. Croteau et PYROPHOSPHATE al. describe in U.S. Pat. No. 6,190,895 the nucleic acid sequences that code for the expression of 1-deoxyxylulose TECHNICAL FIELD 5-phosphate synthase, an enzyme used in one biological 0001. The present invention relates to the biosynthesis of pathway for the synthesis of isopentenyl pyrophosphate. isopentenyl pyrophosphate (IPP) and isoprenoids derived Low yields of isopentenyl pyrophosphate remain, however, therefrom. More particularly, the invention relates to meth since several more enzymes are needed to catalyze other ods for biosynthesizing isopentenyl pyrophosphate, and to steps in this isopentenyl pyrophosphate biosynthetic path way. Further, the reference does not address an alternative nucleic acid sequences, enzymes, expression vectors, and pathway for isopentenyl pyrophosphate biosynthesis, transformed host cells for carrying out the methods. namely the mevalonate pathway. BACKGROUND 0006 Thus, the current invention is directed toward Solving these and other disadvantages in the art by increas 0002) Isoprenoids are compounds derived from the five ing the typically low yields associated with conventional carbon molecule, isopentenyl pyrophosphate. Investigators synthesis of isopentenyl pyrophosphate and isoprenoids. have identified over 29,000 individual isoprenoid com Specifically, the current invention is directed toward iden pounds, with new ones continuously being discovered. Iso tification of new methods for the synthesis of isopentenyl prenoids are often isolated from natural products, such as pyrophosphate, as isopentenyl pyrophosphate represents the plants and microorganisms, which use isopentenyl pyro universal precursor to isoprenoid synthesis. phosphate as a basic building block to form relatively complex structures. Vital to living organisms, isoprenoids SUMMARY OF THE INVENTION serve to maintain cellular fluidity and electron transport, as 0007 Accordingly, it is an object of the present invention well as function as natural pesticides, to name just a few of to overcome the above-mentioned disadvantages of the prior their roles in vivo. Furthermore, the pharmaceutical and art by providing a method for synthesizing isopentenyl chemical communities use isoprenoids as pharmaceuticals, pyrophosphate in a host microorganism, comprising the step nutriceuticals, flavoring agents, and agricultural pest control of introducing into the host microorganism a plurality of agents. Given their importance in biological systems and heterologous nucleic acid sequences, each coding for a usefulness in a broad range of applications, isoprenoids have different enzyme in the mevalonate pathway for producing been the focus of much attention by scientists. isopentenyl pyrophosphate. 0003 Conventional means for obtaining isoprenoids include extraction from biological materials (e.g., plants, 0008. It is another object of the invention to provide such microbes, and animals) and partial or total organic synthesis a method wherein the plurality of heterologous nucleic acid in the laboratory. Such means, however, have generally sequences is contained in at least one extrachromosomal proven to be unsatisfactory. For example, organic synthesis expression vector. is usually complex since several steps are required to obtain 0009. It is still another object of the invention to provide the desired product. Furthermore, these steps often involve Such a method wherein the isopentenyl pyrophosphate is the use of toxic solvents, which require special handling and further synthesized into an isoprenoid. disposal. Extraction ofisoprenoids from biological materials may also require toxic solvents. In addition, extraction and 0010. It is yet another object of the invention to provide purification methods usually provide a low yield of the such a method wherein the isoprenoid is selected from the desired isoprenoid, as biological materials typically contain group consisting of a monoterpene, sesquiterpene, diterpene, only small quantities of these compounds. Unfortunately, the sesterterpene, triterpene, tetraterpene, and a steroid. difficulty involved in obtaining relatively large amounts of 0011. It is a further object of the invention to provide such isoprenoids has limited their practical use. In fact, the lack a method wherein the plurality of heterologous nucleic acid of readily available methods by which to obtain certain sequences further comprises a DNA fragment coding for an isoprenoids has slowed down the progression of drug can enzyme capable of converting isopentenyl pyrophosphate to didates through clinical trials. Furthermore, once an iso dimethylallyl pyrophosphate. prenoid drug candidate has passed the usual regulatory scrutiny, the actual synthesis of the isoprenoid drug may not 0012. It is still a further object of the invention to provide lend itself to a commercial scale. a method wherein the host microorganism is a prokaryote. 0004 As a solution to such problems, researchers have 0013. It is an additional object of the invention to provide looked to biosynthetic production of isoprenoids. Some a method wherein the prokaryote is Escherichia coli. Success has been obtained in the identification and cloning 0014 Is it still another object of the invention to provide of the genes involved in isoprenoid biosynthesis. For a method for synthesizing isopentenyl pyrophosphate in a example, U.S. Pat. No. 6.291,745 to Meyer et al. describes host microorganism, wherein the method comprises intro the production of limonene and other metabolites in plants. ducing into the host microorganism an intermediate in the Although many of the genes involved in isoprenoid biosyn mevalonate pathway and at least one heterologous nucleic thesis may be expressed in functional form in Escherichia acid sequence, each said sequence coding for an enzyme in coli and other microorganisms, yields remain
Load more

Recommended publications
  • Dietary Supplements Compendium Volume 1
    2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs .
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dry Mouth / Xerostomia
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Dry Mouth / Xerostomia Chemical Activity Count (+)-CATECHIN 2 (+)-EPIPINORESINOL 1 (-)-ANABASINE 1 (-)-EPICATECHIN 2 (-)-EPIGALLOCATECHIN 2 (-)-EPIGALLOCATECHIN-GALLATE 2 (Z)-1,3-BIS(4-HYDROXYPHENYL)-1,4-PENTADIENE 1 1,8-CINEOLE 2 10-METHOXYCAMPTOTHECIN 1 16-HYDROXY-4,4,10,13-TETRAMETHYL-17-(4-METHYL-PENTYL)-HEXADECAHYDRO- 1 CYCLOPENTA[A]PHENANTHREN-3-ONE 2,3-DIHYDROXYBENZOIC-ACID 1 3'-O-METHYL-CATECHIN 1 3-ACETYLACONITINE 1 3-O-METHYL-(+)-CATECHIN 1 4-O-METHYL-GLUCURONOXYLAN 1 5,7-DIHYDROXY-2-METHYLCHROMONE-8-C-BETA-GLUCOPYRANOSIDE 1 5-HYDROXYTRYPTAMINE 1 5-HYDROXYTRYPTOPHAN 1 6-METHOXY-BENZOLINONE 1 ACEMANNAN 1 ACETYL-CHOLINE 1 ACONITINE 2 ADENOSINE 2 AFFINISINE 1 AGRIMONIIN 1 ALANTOLACTONE 2 ALKANNIN 1 Chemical Activity Count ALLANTOIN 1 ALLICIN 2 ALLIIN 2 ALLOISOPTEROPODINE 1 ALLOPTEROPODINE 1 ALLOPURINOL 1 ALPHA-LINOLENIC-ACID 1 ALPHA-TERPINEOL 1 ALPHA-TOCOPHEROL 2 AMAROGENTIN 1 AMELLIN 1 ANABASINE 1 ANDROMEDOTOXIN 1 ANETHOLE 1 ANTHOCYANIDINS 1 ANTHOCYANINS 1 ANTHOCYANOSIDE 1 APIGENIN 1 APOMORPHINE 1 ARABINO-3,6-GALACTAN-PROTEIN 1 ARABINOGALACTAN 1 ARACHIDONIC-ACID 1 ARCTIGENIN 2 ARECOLINE 1 ARGLABRIN 1 ARISTOLOCHIC-ACID 1 ARISTOLOCHIC-ACID-I 1 2 Chemical Activity Count ARMILLARIEN-A 1 ARTEMISININ 1 ASCORBIC-ACID 4 ASTRAGALAN-I 1 ASTRAGALAN-II 1 ASTRAGALAN-III 1 ASTRAGALIN 1 AURICULOSIDE 1 BAICALEIN 1 BAICALIN 1 BAKUCHIOL 1 BENZALDEHYDE 1 BERBAMINE 1 BERBERASTINE 3 BERBERINE 3 BERBERINE-CHLORIDE 1 BERBERINE-IODIDE 1 BERBERINE-SULFATE 1 BETA-AMYRIN-PALMITATE
    [Show full text]
  • Plectranthus Barbatus: a Review of Phytochemistry, Ethnobotanical Uses and Pharmacology – Part 1
    Reviews 653 Plectranthus barbatus: A Review of Phytochemistry, Ethnobotanical Uses and Pharmacology – Part 1 Authors Rawiya H. Alasbahi 1, Matthias F. Melzig 2 Affiliations 1 Faculty of Pharmacy, Department of Pharmacognosy, University of Aden, Crater-Aden, Yemen 2 Institute of Pharmacy, Free University Berlin, Berlin, Germany Key words Abstract liver fatigue, respiratory disorders, heart diseases l" Plectranthus barbatus ! and certain nervous system disorders. Forskolin l" Lamiaceae Plectranthus barbatus Andr. is one of the most im- as one of the major constituents with its unique l" forskolin portant species of the genus Plectranthus L′ Herit. adenylyl cyclase activation that underlies the l" phytochemistry (Lamiaceae), with a wide variety of traditional wide range of pharmacological properties could l" ethnobotanical uses l" pharmacology medicinal uses in Hindu and Ayurvedic tradition- explain the different traditional uses of Plectran- l" 6‑(3‑dimethylaminopropio- al medicine as well as in the folk medicine of Bra- thus barbatus. Forskolin is involved in a number nyl)forskolin hydrochloride zil, tropical Africa and China. The plant has there- of patented pharmaceutical preparations used as (NKH477) fore been an attractive target for intensive chem- over-the-counter drugs for the treatment of sev- ical and pharmacological studies up to now. This eral ailments. However, the water-insoluble na- review presents data about the phytochemistry, ture of forskolin limits its clinical usefulness. For- ethnobotanical uses and pharmacology of Plec- skolin thus served as a prototype for the develop- tranthus barbatus as well as the pharmacology of ment of 6-(3-dimethylaminopropionyl)forskolin its constituents. In addition to essential oil, abie- hydrochloride (NKH477) as a potent water-solu- tane diterpenoids and 8,13-epoxy-labd-14-en- ble forskolin derivative that finds use in the ther- 11-one diterpenoids are the main constituents apy for a number of diseases especially of the car- found in Plectranthus barbatus.
    [Show full text]
  • The Strategies for Production of Forskolin Vis-A- Vis Protection Against Soil Borne Diseases of the Potential Herb Coleus Forskohlii Briq
    . European Journal of Medicinal Plants European 1(1): 1-9, 2011 Journal of Medicinal SCIENCEDOMAIN international Plants www.sciencedomain.org The Strategies for Production of Forskolin vis-a- vis Protection Against Soil Borne Diseases of the Potential Herb Coleus forskohlii Briq. Selima Khatun1, Narayan C. Chatterjee1 and Ugur Cakilcioglu2* 1UGC Centre of Advanced Study, Department of Botany, University of Burdwan, Burdwan 713104, West Bengal, India 2Elazig Directorate of National Education, Dogukent IOO., Elazig 23100, Turkey Received 12th December 2010 Accepted 19th December 2010 th Review Article Available online 28 January 2011 ABSTRACT Coleus forskohlii is an important plant in Indian Ayurvedic medicine. It is the only source for forskolin among the plant kingdom. Forskolin has a unique property of activating almost all hormone sensitive adenylate cyclase enzymes in a biological system. This review article has highlighted on research developments of C. forskohlii for the production and to enhance the production of forskolin by employing various strategies, and also to protect the most potential herb against the soil borne wilt disease, causing a serious threat towards its propagation and cultivation by using effective integrated disease management technology. Keywords: biosynthesis, Coleus forskohlii, forskolin, medicinal plant, tissue culture; 1. INTRODUCTION Forskolin, a labdane diterpene is the active principle of the medicinal plant Coleus forskohlii (Willd.) Briq. [synonym C. barbatus (Andr.) Benth.] of family Lamiaceae. It is an ancient root drug of Indian origin (Shankaragowda, 2000) in Ayurvedic material medica (Shah, 1996). It is reported on morphology, phytochemistry and pharmacological aspects of C. forskohlii (Reddy et al., 2005; Kavitha et al., 2010). Forskolin has a unique property of activating almost all hormone sensitive adenylate cyclase enzymes in a biological system (De Souza and Shah, 1988).
    [Show full text]
  • Adenylate Cyclase Mediates Olfactory Transduction for a Wide Variety of Odorants
    Proc. Natl. Acad. Sci. USA Vol. 86, pp. 5641-5645, July 1989 Neurobiology Adenylate cyclase mediates olfactory transduction for a wide variety of odorants (olfaction/cyclic AMP/cilia/forskolin/sensory transduction) GRAEME LOWE, TADASHI NAKAMURA*, AND GEOFFREY H. GOLD Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104 Communicated by H. C. Berg, April 13, 1989 (receivedfor review January 11, 1988) ABSTRACT An odor-stimulated adenylate cyclase [ATP strong positive correlation between the magnitudes of ade- pyrophosphate-lyase (cyclizing), EC 4.6.1.1] is thought to nylate cyclase stimulation and the EOG responses to 35 mediate olfactory transduction in vertebrates. However, it is odorants. not known whether the adenylate cyclase serves this function We have further investigated the generality of the adenyl- for all odorants or for only certain classes of odorants. To ate cyclase pathway by observing the effects of forskolin on investigate this question, we have compared the abilities of 35 the EOG responses to a variety of different odorants. For- odorants to stimulate the adenylate cyclase and to elicit an skolin stimulates the adenylate cyclase by a direct effect on electrophysiological response. We report a strong positive the enzyme (reviewed in refs. 13 and 14) and therefore, correlation between the magnitude of adenylate cyclase stim- according to the cyclic AMP model (6), should decrease odor ulation and the summated electrical response of the olfactory responses both by its effect on the adenylate cyclase (by epithelium (electro-olfactogram) evoked by individual odor- reducing the number of enzyme molecules that may then be ants. We also show that the adenylate cyclase stimulator activated by odors) and by its effect on the basal cyclic AMP forskolin equally attenuates the electro-olfactogram response concentration (by increasing basal cyclic AMP concentra- for all odorants tested.
    [Show full text]
  • Microbial Synthesis of the Forskolin Precursor Manoyl Oxide in an Enantiomerically Pure Form
    View metadata,Downloaded citation and from similar orbit.dtu.dk papers on:at core.ac.uk Dec 20, 2017 brought to you by CORE provided by Online Research Database In Technology Microbial Synthesis of the Forskolin Precursor Manoyl Oxide in an Enantiomerically Pure Form Nielsen, Morten Thrane; Ranberg, Johan Andersen; Christensen, Ulla; Christensen, Hanne Bjerre; Harrison, Scott James; Olsen, Carl Erik; Hamberger, Björn; Møller, Birger Lindberg; Nørholm, Morten Published in: Applied and Environmental Microbiology Link to article, DOI: 10.1128/AEM.02301-14 Publication date: 2014 Document Version Early version, also known as pre-print Link back to DTU Orbit Citation (APA): Nielsen, M. T., Ranberg, J. A., Christensen, U., Christensen, H. B., Harrison, S. J., Olsen, C. E., ... Nørholm, M. (2014). Microbial Synthesis of the Forskolin Precursor Manoyl Oxide in an Enantiomerically Pure Form. Applied and Environmental Microbiology, 80(23), 7258–7265. DOI: 10.1128/AEM.02301-14 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • Antioxidant Activity of the Medicinal Plant Coleus Forskohlii Briq
    African Journal of Biotechnology Vol. 10(13), pp. 2530-2535, 28 March, 2011 Available online at http://www.academicjournals.org/AJB DOI: 10.5897/AJB10.2526 ISSN 1684–5315 © 2011 Academic Journals Full Length Research Paper Antioxidant activity of the medicinal plant Coleus forskohlii Briq . Selima Khatun 1, Narayan Chandra Chatterjee 1 and Ugur Cakilcioglu 2* 1UGC Centre of Advanced Study, Department of Botany, The University of Burdwan, Burdwan 713104, West Bengal, India. 2Elazı ğ Directorate of National Education, Elazı ğ 23100, Turkey. Accepted 17 March, 2011 Antioxidant status of different parts of Coleus forskohlii including roots, stem, leaves and tubers was analyzed. For the enzymatic antioxidant properties, the activities of superoxide dismutase, peroxidase, polyphenol oxidase and catalase were significantly higher (P < 0.05) in tubers than in the leaves, roots and stem. Among the non-enzymatic antioxidants, except for the chlorophyll and lycopene content, the reducing power and chelating abilities on Fe 2+ , 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity, total phenol, flavonoids and β-carotene were significantly higher (P < 0.05) in tubers than in the leaves, roots and stem, respectively. The tubers possessed significantly rich sources of both enzymatic and non-enzymatic antioxidants besides their medicinal properties. Key words: Coleus forskohlii, roots, stem, leaves, tubers, enzymatic antioxidants, non enzymatic antioxidants. INTRODUCTION Plants and plant-derived products are part of the health- development of age dependent diseases such as cancer, care system since ancient human civilization. Herbal atherosclerosis, arthritis, Alzheimer’s disease, other medicines have been used for many years (Kareru et al., neurodegenerative disorder and other such conditions 2007).
    [Show full text]
  • Use of High Throughput Assays and Computational Tools; Endocrine Disruptor Screening Program; Notice of Availability and Opportunity for Comment’’
    NRDC EPA-HQ-OPPT-2015-0305 August, 2015 Comments from the Natural Resources Defense Council On The Document Titled, ‘‘Use of High Throughput Assays and Computational Tools; Endocrine Disruptor Screening Program; Notice of Availability and Opportunity for Comment’’ To the U.S. Environmental Protection Agency Docket No. EPA-HQ-OPPT-2015-0305 August 18, 2015 Background The Natural Resources Defense Council ("NRDC") is a national, non-profit environmental organization of lawyers, scientists, and other professionals. NRDC presents these comments on behalf of our 1.4 million members and online activists. NRDC does not have any financial interest in the topic of these comments. The endocrine system utilizes highly complex, tightly controlled molecular processes for its optimal functioning in the body. The proper balance of hormones can be synchronized in a variety of ways (including direct protein binding, epigenetic alterations, gene activation and silencing), and is essential across the entirety of the life course. Small changes in the perfectly orchestrated symphony of hormone levels can severely disrupt the harmony necessary for critical windows of development (e.g., fetal development, infanthood, childhood, and adolescence), leaving the body vulnerable to a host of negative health outcomes (such as diabetes, cancer, obesity, and reproductive dysfunction). The last decade has seen an exponential increase in the development of computational, biological, and chemical tools capable of increasing both the number of chemicals analyzed and the pace of chemical toxicity evaluation. These tools, including the EPA Toxicity Forecaster (ToxCast™) and the National Institute of Environmental Health Sciences (NIEHS) Tox21 platforms, have the potential to rapidly generate molecular and cellular data for thousands of chemicals at once, and provide an additional stream of useful information that can aide in regulatory decision-making.
    [Show full text]
  • Analytical Techniques for Phytochemicals Screening and Bioactivities of Some Coleus Species: a Review
    Saraswati et al /J. Pharm. Sci. & Res. Vol. 8(4), 2016, 227-237 Analytical Techniques for Phytochemicals Screening and Bioactivities Of Some Coleus Species: A Review Saraswati, Jatinder Kaur Katnoria and Avinash Kaur Nagpal*. Department of Botanical and Environmental Sciences, Guru Nanak Dev University, Amritsar 143005, India Abstract Medicinal plants are of great significance to health of individuals and communities. Due to their great importance, demand of medicinal plants has increased in numerous fields. Among various plants of medicinal importance, plants of genus Coleus belonging to family Lamiaceae or Labiatae are well known for their biological activities. Flavonoids, glycosides, volatile constituents, phenolic and many other compounds have been reported as the active phytoconstituents of the Coleus species. These isolated and identified bioactive compounds have been analyzed by using phytochemical screening assays, chromatographic techniques (HPLC and TLC), NMR, UV spectroscopy as well as GC-MS. The fundamental aspiration of current review stems for the availability of literature on phytochemicals compounds and biochemical activities of the prominent species of the genus Coleus. Key words: Metabolites, Constituents, Herb, Lamiaceae, Coleus species. INTRODUCTION Among different species of Coleus, C. aromaticus has the Nature has been a source of medicinal agents for thousands tremendous potential as a traditional medicine, probably of years. An impressive number of modern drugs have been due to presence of large number of bioactive compounds. isolated from natural sources that are based on their use in Essential oil of C. aromaticus is rich in carvacrol, thymol, traditional medicine. The genus Coleus (family Lamiaceae) eugenol, chavicol, ethyl salicylate [2] and contains γ- comprises a number of herbaceous medicinal plants which terpinolene (3.75%), pinene (2.50%), β-caryophyllene are particularly employed in home remedies for various (4.20%), methyl eugenol (2.10%), thymol (41.3%), 1,8- ailments.
    [Show full text]
  • Identification of Compounds That Rescue Otic and Myelination Defects
    bioRxiv preprint doi: https://doi.org/10.1101/520056; this version posted January 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Identification of compounds that rescue otic and myelination defects in the 2 zebrafish adgrg6 (gpr126) mutant 3 4 Elvira Diamantopoulou1,*, Sarah Baxendale1,*, Antonio de la Vega de León2, Anzar Asad1, 5 Celia J. Holdsworth1, Leila Abbas1, Valerie J. Gillet2, Giselle R. Wiggin3 and Tanya T. 6 Whitfield1# 7 8 1Bateson Centre and Department of Biomedical Science, University of Sheffield, Sheffield, 9 S10 2TN, UK 10 2Information School, University of Sheffield, Sheffield, S1 4DP, UK 11 3Sosei Heptares, Steinmetz Building, Granta Park, Cambridge, CB21 6DG, UK 12 13 *These authors contributed equally 14 15 #Corresponding author: 16 Tanya T. Whitfield: [email protected] 17 ORCID iD: 0000-0003-1575-1504 18 19 Key words: zebrafish, aGPCR, Adgrg6, Gpr126, phenotypic screening, chemoinformatics, 20 versican, myelination, inner ear, lateral line, Schwann cells 21 22 1 bioRxiv preprint doi: https://doi.org/10.1101/520056; this version posted January 16, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 23 ABSTRACT 24 Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in 25 myelination of the peripheral nervous system.
    [Show full text]
  • PSYCHOACTIVE SUBSTANCES a Guide to Ethnobotanical Plants and Herbs, Synthetic Chemicals, Compounds and Products
    PSYCHOACTIVE SUBSTANCES A Guide to Ethnobotanical Plants and Herbs, Synthetic Chemicals, Compounds and Products. Acknowledgements: Acknowledgement: This Guide was compiled by Sinead O’Mahony Carey, Drug Education Officer, Substance Misuse Service South Tipperary. The Substance Misuse Service would like to thank Aine de Leastar, Anne-Marie Dunne and Karen O’Loughlin for their contribution and endless hours of research and referencing. Health Service Executive South Psychoactive Substances Manual (Edition 1.1) Compiled by: Sinead O’Mahony Carey Drug Education Officer Substance Misuse Service 11-12 Peter St., Clonmel. (052) 6177900 Graphic Design: Leo McCormack (Swift Design - 087 6499990) Introduction The ‘Guide to Ethnobotanical Plants and Herbs, Synthetic Chemicals, Compounds and Products’ available to the Irish Market has been collated and designed by the Drug Education Officer and team in the Substance Misuse Service HSE, South Tipperary. This edition is a follow on to ‘A Guide to Substance Misuse for Medical Professionals’ launched in November 2009. This Guide has been produced in response to requests from workers, users, medical professionals and academics for information on the emerging issue of legal herbal highs, plants and chemical alternatives available to buy in shops and online. Legal highs, legal alternatives and natural highs have become a world wide phenomenon in recent years both here in Ireland and on the International stage. The current concern for users, parents and professionals working with people using and misusing Psychoactive Substances is their after effects and how they can negatively impact on the body and mind. A Psychoactive Substance is a drug (any substance that changes the way a body and mind feels acts or thinks) that is not controlled under the Misuse of Drugs Act 1977-84 and is therefore legal to use and possess.
    [Show full text]
  • 01 Stockley's Herbal Medicines Interactions PRELIMS 1
    HidX`aZn¼h =ZgWVaBZY^X^cZh>ciZgVXi^dch :Y^iZYWn:a^oVWZi]L^aa^Vbhdc!HVbjZa9g^kZgVcY@VgZc7VmiZg Stockley’s Herbal Medicines Interactions Stockley’s Herbal Medicines Interactions A guide to the interactions of herbal medicines, dietary supplements and nutraceuticals with conventional medicines Editors Elizabeth Williamson, BSc, PhD, MRPharmS, FLS Samuel Driver, BSc Karen Baxter, BSc, MSc, MRPharmS Editorial Staff Mildred Davis, BA, BSc, PhD, MRPharmS Rebecca E Garner, BSc C Rhoda Lee, BPharm, PhD, MRPharmS Alison Marshall, BPharm, DipClinPharm, PGCertClinEd, MRPharmS Rosalind McLarney, BPharm, MSc, MRPharmS Jennifer M Sharp, BPharm, DipClinPharm, MRPharmS Digital Products Team Julie McGlashan, BPharm, DipInfSc, MRPharmS Elizabeth King, Dip BTEC PharmSci London . Chicago Published by the Pharmaceutical Press An imprint of RPS Publishing 1 Lambeth High Street, London SE1 7JN, UK 100 South Atkinson Road, Suite 200, Grayslake, IL 60030-7820, USA # Pharmaceutical Press 2009 is a trade mark of RPS Publishing RPS Publishing is the publishing organisation of the Royal Pharmaceutical Society of Great Britain First published 2009 Typeset by Data Standards Ltd, Frome, Somerset Printed in Great Britain by TJ International, Padstow, Cornwall ISBN 978 0 85369 760 2 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, without the prior written permission of the copyright holder. The publisher makes no representation, express or implied, with regard to the accuracy of
    [Show full text]